Dr. Claudia Chiriboga, MD – New York, NY
Overview of Dr. Chiriboga
Dr. Claudia Chiriboga is a Child Neurologist in New York, NY and is affiliated with multiple hospitals in the area, including NewYork-Presbyterian/Columbia University Irving Medical Center and Morgan Stanley Childrens Hospital of NewYork-Presbyterian. She received her medical degree from University of Buenos Aires and has been in practice 38 years. She is one of 23 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 10 doctors at Morgan Stanley Childrens Hospital of NewYork-Presbyterian who specialize in Child Neurology. She has more than 50 publications and over 500 citings.
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Pediatrics, 1982 - 1985
University of Buenos AiresClass of 1982
Certifications & Licensure
NJ State Medical License Current
NY State Medical License 1985 - 2024
MD State Medical License 1984 - 1986
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Publications & Presentations
PubMed
- 1 citations
Digital measures of respiratory and upper limb function in spinal muscular atrophy: design, feasibility, reliability, and preliminary validity of a smartphone sensor-b...
Thanneer Malai Perumal, Detlef Wolf, Doris Berchtold, Grégoire Pointeau, Yan-Ping Zhang, Wei-Yi Cheng, Florian Lipsmeier, Jörg Sprengel, Christian Czech, Claudia A Chi...> ;Neuromuscular Disorders. 2023 Nov 1 - 1 citations
Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study.
Claudia A Chiriboga, Claudio Bruno, Tina Duong, Dirk Fischer, Eugenio Mercuri, Janbernd Kirschner, Anna Kostera-Pruszczyk, Birgit Jaber, Ksenija Gorni, Heidemarie Klet...> ;Neurology and Therapy. 2023 Oct 1 - 5 citations
Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study.
Claudia A Chiriboga, Claudio Bruno, Tina Duong, Dirk Fischer, Eugenio Mercuri, Janbernd Kirschner, Anna Kostera-Pruszczyk, Birgit Jaber, Ksenija Gorni, Heidemarie Klet...> ;Neurology and Therapy. 2023 Apr 1 - Join now to see all
Press Mentions
Positive New Data for Genentech’s Evrysdi in Largest Trial Ever Undertaken in Patients with Previously-Treated Spinal Muscular Atrophy (SMA)October 12th, 2022
New Genentech Data for Evrysdi (Risdiplam) Show Improved Motor Function in Pre-Symptomatic Babies After One Year and Confirm Safety Profile in Previously Treated People with Spinal Muscular Atrophy (SMA)June 11th, 2021
